44 New York State Lawmakers Urge Cuomo to Reverse Medicaid Drug Benefit Transfer

Forty-four New York state legislators have signed a letter to Gov. Andrew Cuomo (D) expressing “strong opposition” to the scheduled transfer in April of Medicaid managed care pharmacy benefits to Medicaid fee for service. They said the transfer “will have

Read More »

TV Humorist Bestows “Baldy” Award on Co-Author of 340B Law

Humorist Bill Maher says making "real progress" in Congress comes from "dull patient plodders" like Henry Waxman, the inspiration for and first recipient of Maher's new Baldy Award. | Source: YouTube

Humorist Bill Maher, host of HBO’s long-running Real Time with Bill Maher program, on Friday “honored” former U.S. House Energy and Commerce Chair Henry Waxman (D-Calif.) with a new award for unheralded public service—the Baldy. Waxman was a driving force

Read More »

Portman’s Retirement in 2023 Will Deprive 340B Entities of a Key GOP Ally

U.S. Sen. Rob Portman (R-Ohio) announced yesterday he will not run for reelection in 2022. His retirement will deprive 340B covered entities of a reliable Senate Republican ally come 2023.

Although Portman is not on the Health, Education, Labor, and

Read More »

House E&C Leaders Announce Leadership Team and New Committee Members

U.S. House Energy & Commerce party leaders recently announced new committee members.

U.S. House Energy and Commerce (E&C) Chair Frank Pallone (D-N.J.) last Friday formally announced Rep. Anna Eshoo (D-Calif.) as Health subcommittee chair and Rep. Diana DeGette (D-Colo.) as leader of the Oversight and Investigations subcommittee.

Eshoo, who is based

Read More »

Senate Finance Report Might Shed Light on Insulin Manufacturers’ 340B Contract Pharmacy Actions

HHS has for the second time delayed the effective date of a Trump administration rule to require health centers to provide insulin and injectable epinephrine to low-income patients at the price the centers pay for those drugs under the 340B program. The new date is July 20. | Shutterstock

U.S. insulin manufacturer and pharmacy benefit manager (PBM) business practices “have created a vicious cycle of price increases that have sent costs for patients and taxpayers through the roof,” U.S. Senate Finance Committee leaders Chuck Grassley (R-Iowa) and Ron Wyden

Read More »

Senate Democratic Chairs-in-Waiting Waste No Time Going to Bat for 340B Providers

The incoming Democratic chairs of two key U.S. Senate committees want the federal agency in charge of the 340B program “to take immediate action to clarify that implementation of a rebate model by [drug] manufacturers would violate a material condition

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live